Case | 25 May 2022

Protected: Setterwalls has advised Trill Impact in connection with a private placement in Cinclus Pharma

Responsive image

This content is password-protected. To view it, please enter the password below.

Practice areas:

Private Equity, Life Sciences

  • This field is for validation purposes and should be left unchanged.

Do you want to get in touch with us?

Please fill out the form and we will contact you as soon as possible.

Related news

Setterwalls has advised Integrum AB in connection with a private placement of approximately SEK 22.9 million

Case | 30 September 2026

Setterwalls has advised Integrum AB in connection with a private placement of approximately SEK 22.9 million

Read more
Setterwalls advises Cantargia in connection with a capital raise of approximately SEK 124 million and entering into a loan agreement

Case | 1 June 2026

Setterwalls advises Cantargia in connection with a capital raise of approximately SEK 124 million and entering...

Read more
Setterwalls Life Sciences Report May 2026

Article | 22 May 2026

Setterwalls Life Sciences Report May 2026

Read more
Load more